Paraquat Lawsuit Settlement Amounts in 2026: How Much Could You Receive?
If you or someone you love developed Parkinson’s disease after years of working with paraquat, the hardest question is often the most practical: what could a claim actually be worth? In 2026 there is real movement — a settlement framework is reportedly in place, and a closely watched Philadelphia case settled just before trial in January, a sign the companies want these claims resolved. But here is the honest part: no global settlement has been finalized. So what could a paraquat claim be worth right now?
Quick answer: Estimated paraquat payouts run roughly $100,000–$150,000 on average, with a broader projected range of about $20,000 to $1,000,000 or more, depending on the severity of the Parkinson’s diagnosis, the extent of exposure, and the strength of the evidence. No global settlement has been finalized, so these are analyst estimates — not guarantees. The compensatory portion tied to physical sickness is generally tax-free, while punitive damages and interest are taxable. Filing deadlines vary by state and are time-sensitive.
Paraquat Settlement Amount Estimates
The table below shows the payout ranges legal analysts most often discuss, organized by the case profile each range tends to reflect. Read it as a map, not a price list: these figures come from comparable toxic-tort settlements and from attorneys watching the litigation, not from a confirmed paraquat settlement. The biggest variable is the strength and severity of an individual case, which is why the same diagnosis can sit at very different points in the range.
| Tier | Typical case profile | Estimated range |
|---|---|---|
| Lower | Documented exposure with an early or milder Parkinson’s diagnosis, a shorter exposure history, or causation that is harder to establish. | About $20,000–$100,000 |
| Mid | Clear occupational exposure (mixing, loading, or spraying) with a confirmed Parkinson’s diagnosis and solid medical records. | About $100,000–$300,000 |
| Higher | Long, intense exposure with advanced or progressive Parkinson’s, strong causation evidence, and a significant impact on daily life. | About $300,000–$1,000,000 |
| Exceptional | The most severe injuries, extensive documentation, and aggravating factors. Some analysts cite figures approaching the top of this range. | Up to about $1,500,000 |
Again, no global paraquat settlement has been finalized, and the cases resolved so far were settled confidentially — so there is no verified per-person figure. Treat every number here as an estimate that may change.
Quick Answers to the Top Questions
How much is a paraquat settlement per person?
Analyst estimates commonly cluster around $100,000–$150,000 on average, with a broader projected band of roughly $20,000 to more than $1,000,000. Nothing is guaranteed, and a single case’s value depends on the factors below. See what determines your payout.
Who qualifies?
Generally, people exposed to paraquat — by mixing, loading, spraying, or working and living near where it was applied — who were later diagnosed with Parkinson’s disease. Families can sometimes file on behalf of a loved one. See who qualifies.
Is there a settlement yet?
Not a finalized global one. A settlement framework has been reported since April 2025, cases have settled confidentially, and a court-supervised settlement fund was authorized in early 2026 — but final terms are not yet approved. See the 2026 update.
How long until payouts?
There is no firm date. Once a settlement is finalized and a claims process opens, payments in mass torts typically take months to a couple of years. See the timeline.
Is it taxable?
The compensatory portion for a physical sickness like Parkinson’s is generally tax-free; punitive damages and interest are taxable. See the tax section and speak with a tax professional.
Is There a Paraquat Settlement Yet? (2026 Update)
Status as of mid-June 2026 — verify current details, because this litigation moves quickly.
The federal cases are consolidated in MDL No. 3004, In re: Paraquat Products Liability Litigation, before Chief Judge Nancy J. Rosenstengel in the U.S. District Court for the Southern District of Illinois. As of early June 2026, the docket held roughly 6,650 pending cases, with more in state courts. The primary defendants are Syngenta (the manufacturer) and Chevron (a former distributor). This is a multidistrict litigation, not a class action — a distinction that matters, because each case keeps its own individual value rather than splitting a single shared award.
Here is how the picture has developed:
- April 2025 — settlement framework. The parties reported a settlement in principle, signing a letter agreement to resolve a large share of the MDL. The framework is described as largely in place, though some plaintiff firms have objected to certain terms.
- Through 2025 — repeated stays. The court paused case-specific deadlines several times and vacated a bellwether trial date so the two sides could keep negotiating.
- January 27, 2026 — Philadelphia bellwether settled. The first paraquat case set for trial in Philadelphia state court settled confidentially the night before opening arguments — part of a pattern of defendants settling on the courthouse steps that many read as a desire to avoid a jury verdict.
- March 2026 — settlement fund and a production wind-down. The court authorized a qualified settlement fund to help administer a broader resolution, and a scheduled trial was canceled in light of the pending settlement. Around the same time, Syngenta announced it would discontinue paraquat production — framing the move as a shift to newer technology.
- April 27, 2026 — Supreme Court argument. The U.S. Supreme Court heard oral argument in Monsanto v. Durnell, a Roundup case asking whether federal pesticide law (FIFRA) preempts state failure-to-warn claims when the EPA has not required the warning. A decision is expected in 2026 but has not yet issued. Because paraquat claims rest on a similar theory, the ruling could influence them.
The takeaway: momentum is real, but a finalized, publicly disclosed global settlement does not exist yet. Anyone telling you a specific guaranteed amount is getting ahead of the facts.
What Determines Your Payout?
If a settlement is reached, individual amounts will not be uniform. In mass torts, claims are typically scored against a set of factors, and stronger evidence with a more severe diagnosis anchors the higher estimates. The main considerations:
- Severity and progression of Parkinson’s. Advanced, disabling, or fast-progressing disease generally supports a higher valuation than an early or mild diagnosis.
- Exposure duration and intensity. Years of hands-on mixing, loading, and spraying carry more weight than brief or incidental contact.
- Documentation quality. Medical records confirming the diagnosis, plus records establishing exposure, can make or break a claim’s strength.
- Causation strength. A clear, well-supported link between the exposure and the diagnosis — including timing — is central.
- Age and life impact. A younger claimant facing decades of care and lost earnings may be valued differently, and quality-of-life effects matter.
- Venue. Where a case is filed can affect its value, because juries and state laws vary.
For context, analysts often benchmark paraquat estimates against the Roundup litigation, where Bayer paid out billions to resolve a very large number of weed-killer cancer claims. That comparison is one reason the $100,000–$150,000 average circulates — but it is a projection, and the two products and their science are not identical.
Who Qualifies for the Paraquat Lawsuit?
Eligibility generally turns on two things together: documented exposure to paraquat and a confirmed diagnosis of Parkinson’s disease. Exposure is not limited to the person holding the sprayer — people who mixed or loaded the chemical, worked in or near treated fields, or lived close to where it was applied may also have a claim. The table below outlines the most common groups.
| Group | Typical exposure | Core requirement |
|---|---|---|
| Licensed commercial applicators | Routinely mixed, loaded, and sprayed paraquat as part of the job. | Confirmed Parkinson’s diagnosis plus documented exposure. |
| Farmers and agricultural workers | Applied paraquat on crops or worked treated fields over months or years. | Confirmed Parkinson’s diagnosis plus an exposure history. |
| Farmworkers and field laborers | Worked near application, handled equipment, or re-entered sprayed fields. | Confirmed Parkinson’s diagnosis plus evidence of proximity or contact. |
| Residents and bystanders | Lived or worked close to fields where paraquat was sprayed (for example, through drift). | Confirmed Parkinson’s diagnosis plus a credible exposure link. |
| Family members | Filing for a loved one who has died or cannot file on their own. | Diagnosis and exposure records; wrongful-death rules vary by state. |
If a loved one passed away from complications of Parkinson’s after paraquat exposure, surviving family members may be able to bring a claim. Those situations follow separate rules — our overview of wrongful death claims explains how that path differs. An attorney is the right person to confirm whether a specific situation qualifies.
What Symptoms and Conditions Qualify?
The qualifying condition is Parkinson’s disease — and, in some cases, related parkinsonism diagnosed by a physician. Parkinson’s is a progressive neurodegenerative disorder, and the symptoms most often associated with a diagnosis include:
- Tremor — shaking that frequently begins in a hand or fingers, often when the limb is at rest.
- Bradykinesia — a general slowing of movement that can make everyday tasks take much longer.
- Rigidity — muscle stiffness that may be painful and limit range of motion.
- Postural instability — impaired balance and coordination that raises the risk of falls.
Other changes — a softening voice, reduced facial expression, smaller handwriting, or a diminished sense of smell — can accompany the disease. For a claim, the essential combination is a physician-confirmed diagnosis paired with a documented history of paraquat exposure. A diagnosis alone, or exposure alone, is generally not enough; the two need to be connected.
What Is Paraquat — and the Parkinson’s Link?
Paraquat dichloride is a fast-acting herbicide used widely in U.S. agriculture, often sold as Gramoxone and frequently applied where weeds have grown resistant to glyphosate. It is highly toxic; the U.S. Environmental Protection Agency classifies every paraquat product registered in the country as a Restricted Use Pesticide, meaning it can be handled only by trained, certified applicators, with no residential uses — see the EPA’s paraquat dichloride page. It has been banned in dozens of countries — by many counts more than 60, including the European Union and China — though it remains legal in the United States under restricted-use rules.
Exposure typically happens through skin contact, inhaling spray or mist, or accidental ingestion during mixing, loading, application, or cleanup, and through drift onto nearby people. The concern driving the lawsuits is the connection to Parkinson’s. Research funded by the National Institute of Environmental Health Sciences reported that people who occupationally used paraquat (or the pesticide rotenone) developed Parkinson’s disease about 2.5 times more often than non-users, and a long-running study identified paraquat among the pesticides that contribute to the disease’s onset and progression. The NIEHS overview of the environmental links to Parkinson’s disease summarizes this work. The claims center not on the chemical’s existence but on an alleged failure to adequately warn users of that risk.
Paraquat is one of several toxic-exposure fights moving through the courts. If you are researching how these cases work, our guides to the Camp Lejeune toxic-water litigation and the AFFF firefighting-foam lawsuits cover parallel injury claims, and our explainer on product liability claims covers the failure-to-warn theory that underlies them.
Is a Paraquat Settlement Taxable?
The answer is split, and the distinction matters. Under Internal Revenue Code §104(a)(2), money received as compensation for a physical injury or physical sickness — which is what a Parkinson’s diagnosis represents — is generally not taxable. But other components are treated differently, as the table below summarizes.
| Settlement component | Generally taxable? |
|---|---|
| Compensatory damages for the physical sickness (the Parkinson’s injury) | No — generally tax-free under IRC §104(a)(2). |
| Emotional distress arising from the physical sickness | Generally tax-free when it originates from the physical injury. |
| Previously deducted medical expenses now recovered | Yes — taxable to the extent the deduction gave a tax benefit before. |
| Punitive damages | Yes — taxable, and generally reported as other income. |
| Interest on the award | Yes — taxable. |
Because the taxable pieces — punitive damages and interest — can arrive in the same check as the tax-free compensatory portion, it helps to know which is which before you spend anything. For some claimants, a structured settlement that spreads payments over time can help manage taxes and preserve eligibility for income-based benefits. None of this is tax advice — the IRS’s Publication 4345 on the taxability of settlements is a useful starting point, but the right move is to review your specific situation with a qualified tax professional.
How Long Until You Get Paid?
There is no honest way to give a firm date, because no global settlement has been finalized. What we can say is how these timelines usually unfold. Once a mass-tort settlement is finalized and a claims administrator opens the process, claimants submit documentation, cases are reviewed and scored, and payments are issued in stages — generally over several months to a couple of years.
Two things commonly slow the amount that lands in your bank account: liens — sums that Medicare, Medicaid, or private insurers may recover for related care — and the time it takes to verify each claim. The 2026 authorization of a qualified settlement fund is the kind of structure that helps administer payments once terms are set, but it is not the same as money going out the door.
How to File a Paraquat Claim
This section is informational, not a solicitation. In broad strokes:
- Confirm and document the diagnosis. Gather medical records showing a physician’s diagnosis of Parkinson’s disease or parkinsonism.
- Reconstruct the exposure history. Collect whatever establishes contact with paraquat — applicator licenses, employment records, farm or supplier records, purchase receipts, or a detailed account of when, where, and how exposure happened.
- Mind the deadline. Every claim is governed by a statute of limitations that varies by state. Missing it can permanently bar a claim, which is why this is time-sensitive — without being a reason to panic.
- Consult a licensed attorney. A lawyer experienced in toxic-exposure litigation can assess eligibility and explain your options. These cases are typically handled on contingency, meaning no upfront cost and a fee only if the case recovers money.
Because paraquat is an MDL rather than a class action, joining is not automatic — each claimant files an individual case. To understand how that differs, our guide on how to file a class action lawsuit walks through the contrast.
What to Know Before You Settle
A settlement figure is rarely the amount that reaches your pocket, and clear expectations protect you. A few calm, practical points:
- The headline number is not your net. If you hear “$50,000,” that is the gross. Contingency attorney fees, case costs, and any medical or government liens come out first, so the in-hand amount is lower. Ask your attorney for a written estimate of all three.
- Keep your case off social media. Posting about your diagnosis, exposure, or case can be used against you, so it is best to avoid discussing details publicly while a claim is active.
- Think about how you receive the money. A lump sum and a structured payout can affect your taxes and income-based benefits differently. Weigh both before you sign.
- Set aside the taxable portion. Punitive damages and interest are taxable even when the core compensatory award is not — knowing the split in advance avoids a surprise at tax time.
- Be skeptical of guarantees. No one can promise a specific amount while the global settlement is unfinalized. A “guaranteed” payout is a red flag, not a reassurance.
Frequently Asked Questions
- How much are paraquat settlement amounts per person?
- Analyst estimates commonly run about $100,000–$150,000 on average, within a broader projected range of roughly $20,000 to more than $1,000,000. No global settlement has been finalized, so these are projections, not guaranteed figures, and the cases settled so far have been confidential.
- Is there a paraquat settlement yet in 2026?
- Not a finalized, publicly disclosed global settlement. A settlement framework has been reported since April 2025, a qualified settlement fund was authorized in early 2026, and individual cases have settled confidentially — but final terms are not yet approved. Verify the current status, as this changes quickly.
- Who qualifies for the paraquat lawsuit?
- Generally, people exposed to paraquat through mixing, loading, spraying, or working and living near application sites, who were later diagnosed with Parkinson’s disease. Families may be able to file on behalf of a loved one. An attorney can confirm eligibility for a specific situation.
- What is the average paraquat settlement?
- The figure most often cited by legal analysts is roughly $100,000–$150,000, benchmarked against comparable herbicide litigation. It is an estimate. Because settlements to date are confidential and no global deal is final, there is no verified public average yet.
- Is a paraquat settlement taxable?
- The compensatory portion for the physical sickness (Parkinson’s) is generally tax-free under IRC §104(a)(2). Punitive damages and interest are taxable, and recovered medical expenses you previously deducted may be too. Consult a tax professional about your specific award.
- How long does a paraquat settlement take?
- There is no firm timeline because no global settlement is finalized. Once a settlement and claims process are in place, payments in mass torts generally take several months to a couple of years, and liens and claim verification can extend that.
- What evidence do I need for a paraquat lawsuit?
- The core is a physician-confirmed Parkinson’s diagnosis plus documentation of paraquat exposure — for example, applicator licenses, employment or farm records, purchase records, and a detailed exposure history. Stronger documentation tends to support stronger claims.
- How much of a $50,000 settlement will I actually receive?
- Less than $50,000. Contingency attorney fees, case costs, and any medical or government liens are deducted first, so the net in hand is lower. The exact reduction depends on your fee agreement and your liens — ask your attorney for a written breakdown.
- What companies are being sued over paraquat?
- The primary defendants in the federal MDL are Syngenta, the manufacturer, and Chevron, a former distributor. Various paraquat products — including Gramoxone — are named in the litigation.
- Is there a deadline to file a paraquat claim?
- Yes. A statute of limitations applies, and it varies by state and by the facts of the case. Because missing it can permanently bar a claim, it is wise to confirm the applicable deadline with a licensed attorney sooner rather than later.
Disclaimer: This article is for informational and educational purposes only and is not legal, medical, or tax advice, nor a solicitation for legal services. AdvoraHQ is not a law firm. No global paraquat settlement has been finalized, and any amounts shown are analyst estimates, not guarantees — actual compensation depends on individual circumstances and is not assured. Tax treatment varies by the type of damages. Eligibility and filing deadlines vary by state. Consult a licensed attorney and tax professional, and verify current information through official court and government sources, including the U.S. Supreme Court docket for Monsanto v. Durnell and the U.S. District Court for the Southern District of Illinois, which oversees MDL 3004.
Last updated . Refresh on any settlement, MDL, or Supreme Court development.

Daniel Hayes is the founder and sole researcher at AdvoraHQ. He covers U.S. personal finance, insurance, and consumer law — working directly from IRS publications, federal and state statutes, court opinions, and SEC filings rather than secondary summaries. His focus is the gap between what readers think they know and what the source documents actually say. Daniel is not a licensed attorney, CPA, or financial advisor; his articles are educational and not personalized advice. Reach him at Daniel.Hayes@advorahq.com.



